New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Time of day matters when it comes to cancer diagnosis and treatment, says metastasis study

Time of day matters when it comes to cancer diagnosis and treatment, says metastasis study

byCell PressCredit: Unsplash/CC0 Public DomainYour circadian rhythm doesn't just govern your sleeping schedule; it can also impact cancer development, diagnosis, and treatment. In a review p
Oncology January 23,2024
Time of day matters when it comes to cancer diagnosis and treatment, says metastasis study

Time of day matters when it comes to cancer diagnosis and treatment, says metastasis study

byCell PressCredit: Unsplash/CC0 Public DomainYour circadian rhythm doesn't just govern your sleeping schedule; it can also impact cancer development, diagnosis, and treatment. In a review p
Oncology January 23,2024
Race and geography linked to different risks of breast cancer treatment delays

Race and geography linked to different risks of breast cancer treatment delays

byWileyCredit: Unsplash/CC0 Public DomainFor patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an analysis of 2004–2017 information on patients with br
Oncology January 23,2024
Race and geography linked to different risks of breast cancer treatment delays

Race and geography linked to different risks of breast cancer treatment delays

byWileyCredit: Unsplash/CC0 Public DomainFor patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an analysis of 2004–2017 information on patients with br
Oncology January 23,2024
Impaired histone inheritance accelerates breast cancer growth and metastasis, study shows

Impaired histone inheritance accelerates breast cancer growth and metastasis, study shows

by Li Yuan,Chinese Academy of SciencesCredit: Unsplash/CC0 Public DomainChromatin states and their associated epigenetic information play a crucial role in maintaining the identity of cells as t
Oncology January 23,2024
Impaired histone inheritance accelerates breast cancer growth and metastasis, study shows

Impaired histone inheritance accelerates breast cancer growth and metastasis, study shows

by Li Yuan,Chinese Academy of SciencesCredit: Unsplash/CC0 Public DomainChromatin states and their associated epigenetic information play a crucial role in maintaining the identity of cells as t
Oncology January 23,2024
Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12
Oncology January 23,2024
Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12
Oncology January 23,2024
Minorities face longer wait times for vital lung cancer treatment, study finds

Minorities face longer wait times for vital lung cancer treatment, study finds

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainA new study has revealed significant racial disparities in how quickly minorities with the most common form of lung cancer receive potent
Oncology January 23,2024
Minorities face longer wait times for vital lung cancer treatment, study finds

Minorities face longer wait times for vital lung cancer treatment, study finds

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainA new study has revealed significant racial disparities in how quickly minorities with the most common form of lung cancer receive potent
Oncology January 23,2024
Prostate cancer treatment can wait for most men, study finds

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by
Oncology January 23,2024
Prostate cancer treatment can wait for most men, study finds

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by
Oncology January 23,2024
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA
Oncology January 23,2024
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA
Oncology January 23,2024
Study shows combining AI models improves breast cancer risk assessment

Study shows combining AI models improves breast cancer risk assessment

byRadiological Society of North AmericaFull-field digital mammograms (right mediolateral oblique view) in a 59-year-old woman show (A) the screening mammogram obtained during the study period an
Oncology January 23,2024
Study shows combining AI models improves breast cancer risk assessment

Study shows combining AI models improves breast cancer risk assessment

byRadiological Society of North AmericaFull-field digital mammograms (right mediolateral oblique view) in a 59-year-old woman show (A) the screening mammogram obtained during the study period an
Oncology January 23,2024
How communication in the tumor microenvironment influences tumor development

How communication in the tumor microenvironment influences tumor development

by Goethe UniversityTissue section of a lung tumor showing different cells in the tumor microenvironment: macrophages (red), collagen-producing macrophages or fibrocytes (yellow), fibroblasts (green).
Oncology January 23,2024
How communication in the tumor microenvironment influences tumor development

How communication in the tumor microenvironment influences tumor development

by Goethe UniversityTissue section of a lung tumor showing different cells in the tumor microenvironment: macrophages (red), collagen-producing macrophages or fibrocytes (yellow), fibroblasts (green).
Oncology January 23,2024
RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

by Melissa Pappas, University of Pennsylvania School of Engineering and Applied ScienceCredit: Unsplash/CC0 Public DomainMultiple myeloma is an incurable bone marrow cancer that kills over 100,000 peo
Oncology January 23,2024
RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds

by Melissa Pappas, University of Pennsylvania School of Engineering and Applied ScienceCredit: Unsplash/CC0 Public DomainMultiple myeloma is an incurable bone marrow cancer that kills over 100,000 peo
Oncology January 23,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com